Today

Agents

Chat

Arena

Discover

More

App

Tarsus Pharmaceuticals Q2 EPS USD -0.43 - TARS News | Rallies

Tarsus Pharmaceuticals Q2 EPS USD -0.43

TARS•2026-08-06

Q2 results

Aug. 6 (Reuters) - Tarsus Pharmaceuticals Q2 operating expenses USD 193.82 million.

Q2 net income USD -18.551 million
Q2 product sales USD 173.912 million vs. IBES estimate USD 169.7 million
Q2 basic EPS USD -0.43

Related News

Ingles Markets FY26 Q3 net income slips 1.1% to $25.9 million; net sales rise 1.5% to $1.37 billion

IMKTA•2026-08-06

Mangoceuticals merger partner Nuclea signs MOU with New Mining on modular reactor power for data centers

MGRX•2026-08-06

Britain clears Paramount's $110 billion acquisition of Warner Bros.

PSKY•2026-08-06

Block, Inc. <XYZ.N>: Raymond James Raises Target Price to $97 From $90

SQ•2026-08-06

KKR Real Estate Finance Trust Inc <KREF.N>: Raymond James Raises to Strong Buy From Market Perform

KREF•2026-08-06